Boston Scientific (NYSE:BSX) today reported first-quarter financial results that came in ahead of the Wall Street forecast.
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech ...
April 22 () - Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, overshadowing a ...
CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including ...
Investor's Business Daily on MSN
Boston Scientific slashes guidance; why shares went flying
Boston Scientific stock rallied Wednesday despite cutting its 2026 outlook. An analyst says this could offer a reset for shares.
Boston Scientific (NYSE:BSX | BSX Price Prediction) stock has taken a beating in 2026 after management cut full-year guidance ...
Despite Boston’s Q1 performance denoting a YoY rise of 11.2%, the company has trimmed its full-year growth outlook by 2% at the top-end.
Made Scientific, Inc., a U.S.-based cell therapy contract development and manufacturing organization (CDMO), and Regenicin, ...
Researchers dedicated to a decades-long quest to measure the magnetic properties of the subatomic muon particle have won one ...
AI has already proved itself a valuable scientific tool. Could it take on a more central role in the research process?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results